Prevail™ Paclitaxel Coated PTCA Balloon Catheter
Understand why the Medtronic paclitaxel coated PTCA balloon is an effective treatment option for in-stent restenosis, de novo lesions, and small vessels.
Download brochure
Overview
Right Case Right Time Prevail™
Watch an animation to see why Prevail™ drug-coated balloon offers the performance you want for treating complex lesions during percutaneous coronary interventions.1
Right Case Right Time Prevail™
Prevail™ drug-coated balloon offers the performance you want for treating complex lesions during percutaneous coronary interventions.1
Product details
Device performance
Superior Deliverability2
PowerTrac™ technology and hydrophilic coating enable superior deliverability
- Ultra-slim balloon material for optimised folds
- Low profile marker bands
- Tapered tip
- Lower crossing profile2
- PowerTrac™ technology and hydrophilic coating
- Compatible with 5 F guide catheter
Prevail™ DCB Is Twice As Pushable As IN.PACT™ FALCON DCB†
Drug coating
Proven Freepac Coating5
FreePac coating combines two proven components that work together:
- Paclitaxel — potent antirestenotic drug that remains within tissue throughout the healing process6
- Urea — biocompatible excipient that enables rapid and reliable drug transfer within 30–60 seconds1,3
Clinical Evidence
Building Clinical Evidence
The PREVAIL™ Study adds to the clinical legacy of the IN.PACT™ Falcon Clinical Program.
IN.Pact™ Falcon Clinical Program
- IN.PACT™ Falcon DCB with FreePac coating‡
- 10 trials
- > 1,400 patients
Excellent Results with Prevail™ Study‡5
- Includes complex lesions
- 54.7% ISR
- 75% small vessel in de novo lesions
Ordering Information
| Balloon Length (mm) | |||||
|---|---|---|---|---|---|
| Balloon Diameter (mm) | 10 | 15 | 20 | 25 | 30 |
| 2.0 | PRV020010RX | PRV020015RX | PRV020020RX | PRV020025RX | PRV020030RX |
| 2.25 | PRV022510RX | PRV022515RX | PRV022520RX | PRV022525RX | — |
| 2.50 | PRV025010RX | PRV025015RX | PRV025020RX | PRV025025RX | PRV025030RX |
| 2.75 | PRV027510RX | PRV027515RX | PRV027520RX | PRV027525RX | — |
| 3.0 | PRV030010RX | PRV030015RX | PRV030020RX | PRV030025RX | PRV030030RX |
| 3.5 | PRV035010RX | PRV035015RX | PRV035020RX | PRV035025RX | PRV035030RX |
| 4.0 | PRV040010RX | PRV040015RX | PRV040020RX | PRV040025RX | PRV040030RX |
Downloads
Additional resources
Related Pages
Request more Information
Contact us
*
™Third-party brands are trademarks of their respective owners.
†
99% improved push force compared to IN.PACT™ Falcon DCB.
‡
IN.PACT™ Falcon DCB and Prevail™ DCB use the same FreePac™ coating. PREVAIL Study did not have powered endpoints.
References
1
Prevail Instructions for Use.
2
Compared with IN.PACT Falcon DCB, SeQuent®* Please NEO DCB*, Agent™* DCB, and MagicTouch™* DCB. Deliverability defined as pushability. Based on bench test data, 2020. Bench test data may not be indicative of clinical performance.
3
Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. August 1994;5(2):125-37.
4
Latib A, et al. PREVAIL Study 12-month results. Results presented at PCR 2020.
5
Virmani R. Arterial wall response to drug-coated balloons. Confluence. September 2016;13:15-19.
6
Cremers B, Clever Y, Schaffner S, et al. Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol. October 2010;58(5):583-8.
